Hover Icons

Synimed, manufacturer of SYNICEM™ joins the Biocomposites Group

Synimed, manufacturer of SYNICEM™ joins the Biocomposites Group In 2022, Synimed became part of the Biocomposites Group. Bringing together Synimed’s SYNICEM product range and Biocomposites products, created an unrivalled portfolio of pioneering products for use in bone and soft tissue infection. Based in Keele, UK, with global operations across Europe, USA, Canada, Argentina, China, India and Italy our specialist calcium compounds, bone cements and polymer related products are used in over 1 million procedures in 100 countries every year.

Origins of Company

We consider it our mission to improve the patient’s quality of life and optimize the work of the medical staff by developing state of the art products which stand out for their quality, reliability and efficiency.

SYNICEM™ spacers

Preformed, antibiotic loaded spacers to maintain space and aid treatment of infection

SYNICEM™ spacers

Preformed, antibiotic loaded spacers to maintain space and aid treatment of infection

Download brochure

Preformed spacers to maintain space and aid treatment of infection

The SYNICEM spacer range provides a ready-to-use preformed spacer with the performance characteristics you need for your 2-stage revision procedures.

Designed to overcome the challenges of using traditional intra-operative moulded and handmade spacers, SYNICEM spacers support revisions of the hip, knee and shoulder to preserve articular space and aid the treatment of infection.

SYNICEM™ spacers products

SYNICEM™ SHOULDER SPACER

Specifically designed to support your management of infection in shoulder revision

1-Precision engineered for consistency and structural uniformity
2-Designed for dynamic movement and stability
3-Preloaded with gentamicin to aid treatment of infection
4-Case-by-case flexibility and time-saving

SYNICEM™ KNEE SPACER

Specifically designed to support your management of infection in knee revision

1-Precision engineered for consistency and structural uniformity
2-Designed for dynamic movement and stability
3-Preloaded with gentamicin to aid treatment of infection
4-Case-by-case flexibility and time-saving

SYNICEM™ HIP SPACER

Specifically designed to support your management of infection in hip revision

1-Precision engineered for consistency and structural uniformity
2-Designed for dynamic movement and stability
3-Preloaded with gentamicin to aid treatment of infection
4-Case-by-case flexibility and time-saving

BioComposite Company

Biocomposites is an international medical device company that engineers, manufactures and markets world leading products for use in infection management in bone and soft tissue.

Origins of Company

Based in Keele, UK, it has global operations across Europe, South America, USA, Canada, China and India. Biocomposites is a world leader in the development of innovative calcium compounds and specialty polymer products for surgical use. Its products regenerate bone and target infection risks across a variety of specialties, including musculoskeletal infection, orthopaedics, trauma, spine, foot and ankle, podiatry and sports injuries.

Company across the world

Biocomposites products are now used in over 1 million procedures every year and sold in more than 100 countries around the world.

SYNICEM™ spacers

Preformed, antibiotic loaded spacers to maintain space and aid treatment of infection

International Trade

“Biocomposites’ products are used in over 120,000 procedures every year and is the only supplier providing calcium sulfate antibiotic carriers for use in bone and soft tissue to the NHS. Overseas sales grew by over 200% in a six-year period from 40 countries including the United States, the Netherlands, China, Canada and India.”

Innovation

“Biocomposites identified a significant need to reduce the infection rates from hip and knee replacement surgery. In response they developed STIMULAN Rapid Cure, the first and only calcium sulfate antibiotic carrier that is approved for use in infected bone and soft tissue. The beads in the product deliver an increased level of antibiotics direct to the site of infection and because they absorb as the antibiotic elutes there is no need for further follow-up procedures for the patient.”